Connection

Natasha Ruth to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications Natasha Ruth has written about Recombinant Fusion Proteins.
Natasha Ruth
Connection Strength
0.107
Recombinant Fusion Proteins
  1. Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014 Sep; 66(9):2570-9.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.